Skip to main content
ATRA logo

ATRA · Atara Biotherapeutics, Inc. · Fails to Deliver

Track ATRA — free
$7.93 -0.30 (-3.65%) At close · Nov 12 Q3 2023 earnings call transcript
Market Cap
$80.79M
Shares
10.19M
Volume · Nov 12 16.7K Avg daily vol (3M) 38.48K

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-10-14 2,836 $9.31 $26,403
2026-10-13 1,707 $9.38 $16,012
2026-10-08 216 $9.37 $2,024
2026-10-06 283 $9.40 $2,660
2026-10-05 3,180 $9.48 $30,146
2026-10-01 1,735 $8.50 $14,748
2026-09-29 194 $8.37 $1,624
2026-09-28 3,906 $8.81 $34,412
2026-09-24 828 $8.56 $7,088
2026-09-17 2,316 $10.11 $23,415
2026-09-08 805 $9.76 $7,857
2026-09-01 1,255 $8.90 $11,170
2026-08-21 2,100 $9.38 $19,698
2026-08-20 1,158 $9.60 $11,117
2026-08-19 1,955 $8.72 $17,048
2026-08-18 2,016 $8.36 $16,854
2026-08-17 1,603 $8.09 $12,968
2026-08-13 1,050 $9.23 $9,692
Showing 1–18 of 18 settlements
Key facts CIK 1604464 CUSIP 046513206 13F (30d) 31 filings 18 filers Visit website Investor relations